Sign in to follow
Search Results

0 results for 'Celgene Corporation'

You can use to get even better search results
In re Bristol-Myers Squibb Co. CVR Sec. Litig.
Publication Date: 2024-03-08
Practice Area: Securities Litigation
Industry:
Court: U.S. District Court for the Southern District of New York, U.S. - SDNY
Judge: District Judge Jesse M. Furman
Attorneys:
For plaintiff:
For defendant:
Case number: 21-CV-8255

Plaintiffs Fail to Allege Bristol-Myers Squibb Defendants Acted with Requisite Scienter

October 09, 2023 | The Recorder

Mayo Clinic, Lifepoint Claim Drugmakers Conspired to Delay Generic Competition for Chemo Drug

This suit was surfaced by Law.com Radar. Read the complaint here.
1 minute read
Bernstein v. Bristol-Myers Squibb Co.
Publication Date: 2022-09-30
Practice Area: Civil Procedure | Securities Litigation
Industry:
Court: U.S. District Court for New Jersey
Judge: District Judge McNulty
Attorneys:
For plaintiff:
For defendant:
Case number: 21-20452 (KM) (CLW)

Defendants moved to transfer venue and plaintiff moved to remand his putative class action asserting defendant's Form S-4 registration filed with the SEC pertaining to Contingent Value Rights was false and misleading.

September 29, 2022 | Corporate Counsel

'Don't Leave the Junky Work to Somebody Else': A Veteran Legal Chief Shares Leadership Lessons

"I believe firmly in training each person in the legal department to take over from me—to be my successor," said Stephen Kim, chief legal officer of Avicanna.
8 minute read
June 27, 2022 | Law.com

Law Firm Partner Hiring Increases Across Greater China, Singapore and Tokyo

King & Wood Mallesons raids Fangda for an IP quartet, Atsumi & Sakai gains three in Tokyo and Hill Dickinson gains two in Singapore.
6 minute read
Law Journal Press | Digital Book State Antitrust Law Authors: William T. Lifland View this Book

View more book results for the query "Celgene Corporation"

April 27, 2022 | New Jersey Law Journal

Securities Suit Targets Celgene Multiple Sclerosis and Psoriasis Drugs

This suit was surfaced on Law.com Radar. Read the document here.
1 minute read
December 13, 2021 | New Jersey Law Journal

Bristol-Myers Squibb, Celgene Face Antitrust Suit Over Cancer Drugs

This suit was surfaced by Law.com Radar. Read the document here.
1 minute read
November 10, 2021 | Daily Business Review

Bast Amron, Trenam, Arnold & Porter Among Firms Wading Into Suit Over Pharma Distribution Payments

This lawsuit was surfaced on Law.com Radar. Read the complaint here.
1 minute read
Celgene Corp. v. Mylan Pharm., Inc.
Publication Date: 2021-11-10
Practice Area: Civil Procedure | Intellectual Property
Industry:
Court: U.S. District Court for New Jersey
Judge: Chief Judge Prost
Attorneys:
For plaintiff:
For defendant:
Case number: 2021-1154

Plaintiff appealed the District Court's dismissal of its complaint for improper venue and failure to state a claim.

October 15, 2021 | New Jersey Law Journal

Patent Infringement Suit Against Bristol-Myers, Celgene Targets Multiple Sclerosis Treatment

This suit was surfaced by Law.com Radar. Read the document here.
1 minute read

TRENDING STORIES

    More from ALM

    More from ALM

    Legal Speak is a weekly podcast that makes sense of what’s happening in the legal industry.

    Resources

    • A Buyer's Guide to Law Firm Software

      Brought to you by PracticePanther

      Download Now

    • A Step-by-Step Flight Plan for Legal Teams: Fire Up Your Productivity Engine and Deliver High-Impact Work Faster

      Brought to you by HaystackID

      Download Now

    • Corporate Transparency Act Resource Kit

      Brought to you by Wolters Kluwer

      Download Now

    • Revenue, Profit, Cash: Managing Law Firms for Success

      Brought to you by Juris Ledger

      Download Now